Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Infectomics Screening for Novel Antiviral Drug Targets

Identifieur interne : 001410 ( Main/Merge ); précédent : 001409; suivant : 001411

Infectomics Screening for Novel Antiviral Drug Targets

Auteurs : Yuan Liu [République populaire de Chine] ; Qi Yin [République populaire de Chine] ; Yao Yuan [République populaire de Chine] ; Wenyong Yang [République populaire de Chine] ; Chuangui Jiang [République populaire de Chine] ; Canhua Huang [République populaire de Chine]

Source :

RBID : ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D

English descriptors

Abstract

Preclinical Research Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering RNA screening, and micro RNA profiling, have been gradually employed in the research of virus–host interactions. Besides, signaling pathways and cellular processes involved in viral–host interactions provide new insights of infectomics in antiviral drug discovery. In this review, we summarize related infectomics approaches in the studies of virus–host interactions, which shed light on the development of novel antiviral drug targets screening.

Url:
DOI: 10.1002/ddr.21027

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/ddr.21027</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-K4XR5H06-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000431</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000431</idno>
<idno type="wicri:Area/Istex/Curation">000431</idno>
<idno type="wicri:Area/Istex/Checkpoint">000469</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000469</idno>
<idno type="wicri:doubleKey">0272-4391:2012:Liu Y:infectomics:screening:for</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163650</idno>
<idno type="RBID">PMC:7163650</idno>
<idno type="wicri:Area/Pmc/Corpus">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000899</idno>
<idno type="wicri:Area/Pmc/Curation">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000899</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000856</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000856</idno>
<idno type="wicri:Area/Ncbi/Merge">001350</idno>
<idno type="wicri:Area/Ncbi/Curation">001350</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001350</idno>
<idno type="wicri:doubleKey">0272-4391:2012:Liu Y:infectomics:screening:for</idno>
<idno type="wicri:Area/Main/Merge">001410</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Drug Development Research</title>
<title level="j" type="sub">Impact of Omics on Drug Discovery and Development. Part I</title>
<title level="j" type="alt">DRUG DEVELOPMENT RESEARCH</title>
<idno type="ISSN">0272-4391</idno>
<idno type="eISSN">1098-2299</idno>
<imprint>
<biblScope unit="vol">73</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="365">365</biblScope>
<biblScope unit="page" to="380">380</biblScope>
<biblScope unit="page-count">16</biblScope>
<date type="published" when="2012-11">2012-11</date>
</imprint>
<idno type="ISSN">0272-4391</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0272-4391</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Activitybased protein</term>
<term>Anal chem</term>
<term>Antimicrobial drug discovery</term>
<term>Antisense inhibitors</term>
<term>Antiviral</term>
<term>Antiviral drug discovery</term>
<term>Antiviral therapy</term>
<term>Apoptosis</term>
<term>Assay</term>
<term>Autophagy</term>
<term>Biol</term>
<term>Biotechnol</term>
<term>Brain tumor cells</term>
<term>Caenorhabditis elegans</term>
<term>Canhua huang</term>
<term>Cell host microbe</term>
<term>Cellular</term>
<term>Cellular functions</term>
<term>Cellular mirnas</term>
<term>Cellular processes</term>
<term>Chem</term>
<term>Chemical genomics</term>
<term>Chemical infectomics</term>
<term>Chemical probes</term>
<term>Clin</term>
<term>Clin microbiol</term>
<term>Collisional activation</term>
<term>Complex proteomes</term>
<term>Critical role</term>
<term>Cultured cells</term>
<term>Curr</term>
<term>Curr drug targets</term>
<term>Cysteine proteases</term>
<term>Dengue</term>
<term>Dengue virus</term>
<term>Denv</term>
<term>Drug discovery</term>
<term>Drug resistance</term>
<term>Drug targets</term>
<term>Escherichia coli bacteriophage</term>
<term>Essential roles</term>
<term>Expert opin</term>
<term>Expression monitoring</term>
<term>Functional genomic analysis</term>
<term>Functional genomic screen</term>
<term>Functional transcription factor</term>
<term>Gene acquisition</term>
<term>Gene expression</term>
<term>Genet</term>
<term>Genome</term>
<term>Genomic</term>
<term>Genomics</term>
<term>Glucose metabolism</term>
<term>Hepatitis</term>
<term>Hepatocellular carcinoma</term>
<term>Hepatoma cells</term>
<term>Hepg2 cells</term>
<term>Herpes simplex virus</term>
<term>Host cell invasion</term>
<term>Host cells</term>
<term>Host factors</term>
<term>Host interactions</term>
<term>Host perspective</term>
<term>Host proteins</term>
<term>Host response</term>
<term>Huang</term>
<term>Human cytomegalovirus</term>
<term>Human genome project</term>
<term>Human host factors</term>
<term>Human proteins</term>
<term>Human virus</term>
<term>Ight mass spectrometry</term>
<term>Important role</term>
<term>Important roles</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Infectomics</term>
<term>Infectomics approaches</term>
<term>Infectomics screening</term>
<term>Infectomics view</term>
<term>Inhibitor</term>
<term>Kinase</term>
<term>Large number</term>
<term>Liver hepatitis</term>
<term>Mass proteomics</term>
<term>Membrane receptors</term>
<term>Microarray</term>
<term>Microarray analysis</term>
<term>Microarrays</term>
<term>Microbial</term>
<term>Microbial infections</term>
<term>Microbial pathogens</term>
<term>Microbiol</term>
<term>Microrna</term>
<term>Micrornas</term>
<term>Mirna</term>
<term>Mirnas</term>
<term>Mrna</term>
<term>Mutation</term>
<term>Nonstructural protein</term>
<term>Ns4b protein</term>
<term>Nuclear factor kappa</term>
<term>Nuclear receptors</term>
<term>Omics approaches</term>
<term>Online issue</term>
<term>Opin</term>
<term>Other viruses</term>
<term>Pathogen</term>
<term>Pathway</term>
<term>Physical interaction</term>
<term>Plo</term>
<term>Point mutation</term>
<term>Precore region</term>
<term>Previous studies</term>
<term>Prey proteins</term>
<term>Proc natl acad</term>
<term>Protease</term>
<term>Protease inhibitors</term>
<term>Protein</term>
<term>Protein kinase</term>
<term>Protein microarray analysis</term>
<term>Protein microarrays</term>
<term>Proteome</term>
<term>Proteomic</term>
<term>Proteomic analysis</term>
<term>Proteomic approach</term>
<term>Proteomic approaches</term>
<term>Proteomics</term>
<term>Quantitative analysis</term>
<term>Receptor</term>
<term>Replication</term>
<term>Reporter gene</term>
<term>Rnai</term>
<term>Rnai screen</term>
<term>Rnai screening</term>
<term>Sample consumption</term>
<term>Schematic view</term>
<term>Screening</term>
<term>Sichuan university</term>
<term>Sirna screening</term>
<term>Solid substrate</term>
<term>Spectrometry</term>
<term>Syncytial virus</term>
<term>Systems biology</term>
<term>Transcription</term>
<term>Transcription factors</term>
<term>Tumor suppression</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Viral encoding proteins</term>
<term>Viral infection</term>
<term>Viral infections</term>
<term>Viral perspective</term>
<term>Viral proteins</term>
<term>Viral replication</term>
<term>Viral strategies</term>
<term>Viral transcription</term>
<term>Virol</term>
<term>Virology</term>
<term>Virus</term>
<term>Virus core protein</term>
<term>Virus infection</term>
<term>Virus nonstructural protein</term>
<term>Virus replication</term>
<term>Wang</term>
<term>West china</term>
<term>West china hospital</term>
<term>Wiley periodicals</term>
<term>Yeast</term>
<term>Yeast assay</term>
<term>Yeast host cell</term>
<term>Yeast system</term>
<term>Zhang</term>
<term>Zhou</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Preclinical Research Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering RNA screening, and micro RNA profiling, have been gradually employed in the research of virus–host interactions. Besides, signaling pathways and cellular processes involved in viral–host interactions provide new insights of infectomics in antiviral drug discovery. In this review, we summarize related infectomics approaches in the studies of virus–host interactions, which shed light on the development of novel antiviral drug targets screening.</div>
</front>
</TEI>
<double doi="10.1002/ddr.21027">
<ISTEX>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/ddr.21027</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-K4XR5H06-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000431</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000431</idno>
<idno type="wicri:Area/Istex/Curation">000431</idno>
<idno type="wicri:Area/Istex/Checkpoint">000469</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000469</idno>
<idno type="wicri:doubleKey">0272-4391:2012:Liu Y:infectomics:screening:for</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The State Key Laboratory of Biotherapy, West China Hospital, West China, Sichuan University, 610041, Chengdu</wicri:regionArea>
<wicri:noRegion>Chengdu</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Drug Development Research</title>
<title level="j" type="sub">Impact of Omics on Drug Discovery and Development. Part I</title>
<title level="j" type="alt">DRUG DEVELOPMENT RESEARCH</title>
<idno type="ISSN">0272-4391</idno>
<idno type="eISSN">1098-2299</idno>
<imprint>
<biblScope unit="vol">73</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="365">365</biblScope>
<biblScope unit="page" to="380">380</biblScope>
<biblScope unit="page-count">16</biblScope>
<date type="published" when="2012-11">2012-11</date>
</imprint>
<idno type="ISSN">0272-4391</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0272-4391</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Activitybased protein</term>
<term>Anal chem</term>
<term>Antimicrobial drug discovery</term>
<term>Antisense inhibitors</term>
<term>Antiviral</term>
<term>Antiviral drug discovery</term>
<term>Antiviral therapy</term>
<term>Apoptosis</term>
<term>Assay</term>
<term>Autophagy</term>
<term>Biol</term>
<term>Biotechnol</term>
<term>Brain tumor cells</term>
<term>Caenorhabditis elegans</term>
<term>Canhua huang</term>
<term>Cell host microbe</term>
<term>Cellular</term>
<term>Cellular functions</term>
<term>Cellular mirnas</term>
<term>Cellular processes</term>
<term>Chem</term>
<term>Chemical genomics</term>
<term>Chemical infectomics</term>
<term>Chemical probes</term>
<term>Clin</term>
<term>Clin microbiol</term>
<term>Collisional activation</term>
<term>Complex proteomes</term>
<term>Critical role</term>
<term>Cultured cells</term>
<term>Curr</term>
<term>Curr drug targets</term>
<term>Cysteine proteases</term>
<term>Dengue</term>
<term>Dengue virus</term>
<term>Denv</term>
<term>Drug discovery</term>
<term>Drug resistance</term>
<term>Drug targets</term>
<term>Escherichia coli bacteriophage</term>
<term>Essential roles</term>
<term>Expert opin</term>
<term>Expression monitoring</term>
<term>Functional genomic analysis</term>
<term>Functional genomic screen</term>
<term>Functional transcription factor</term>
<term>Gene acquisition</term>
<term>Gene expression</term>
<term>Genet</term>
<term>Genome</term>
<term>Genomic</term>
<term>Genomics</term>
<term>Glucose metabolism</term>
<term>Hepatitis</term>
<term>Hepatocellular carcinoma</term>
<term>Hepatoma cells</term>
<term>Hepg2 cells</term>
<term>Herpes simplex virus</term>
<term>Host cell invasion</term>
<term>Host cells</term>
<term>Host factors</term>
<term>Host interactions</term>
<term>Host perspective</term>
<term>Host proteins</term>
<term>Host response</term>
<term>Huang</term>
<term>Human cytomegalovirus</term>
<term>Human genome project</term>
<term>Human host factors</term>
<term>Human proteins</term>
<term>Human virus</term>
<term>Ight mass spectrometry</term>
<term>Important role</term>
<term>Important roles</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Infectomics</term>
<term>Infectomics approaches</term>
<term>Infectomics screening</term>
<term>Infectomics view</term>
<term>Inhibitor</term>
<term>Kinase</term>
<term>Large number</term>
<term>Liver hepatitis</term>
<term>Mass proteomics</term>
<term>Membrane receptors</term>
<term>Microarray</term>
<term>Microarray analysis</term>
<term>Microarrays</term>
<term>Microbial</term>
<term>Microbial infections</term>
<term>Microbial pathogens</term>
<term>Microbiol</term>
<term>Microrna</term>
<term>Micrornas</term>
<term>Mirna</term>
<term>Mirnas</term>
<term>Mrna</term>
<term>Mutation</term>
<term>Nonstructural protein</term>
<term>Ns4b protein</term>
<term>Nuclear factor kappa</term>
<term>Nuclear receptors</term>
<term>Omics approaches</term>
<term>Online issue</term>
<term>Opin</term>
<term>Other viruses</term>
<term>Pathogen</term>
<term>Pathway</term>
<term>Physical interaction</term>
<term>Plo</term>
<term>Point mutation</term>
<term>Precore region</term>
<term>Previous studies</term>
<term>Prey proteins</term>
<term>Proc natl acad</term>
<term>Protease</term>
<term>Protease inhibitors</term>
<term>Protein</term>
<term>Protein kinase</term>
<term>Protein microarray analysis</term>
<term>Protein microarrays</term>
<term>Proteome</term>
<term>Proteomic</term>
<term>Proteomic analysis</term>
<term>Proteomic approach</term>
<term>Proteomic approaches</term>
<term>Proteomics</term>
<term>Quantitative analysis</term>
<term>Receptor</term>
<term>Replication</term>
<term>Reporter gene</term>
<term>Rnai</term>
<term>Rnai screen</term>
<term>Rnai screening</term>
<term>Sample consumption</term>
<term>Schematic view</term>
<term>Screening</term>
<term>Sichuan university</term>
<term>Sirna screening</term>
<term>Solid substrate</term>
<term>Spectrometry</term>
<term>Syncytial virus</term>
<term>Systems biology</term>
<term>Transcription</term>
<term>Transcription factors</term>
<term>Tumor suppression</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Viral encoding proteins</term>
<term>Viral infection</term>
<term>Viral infections</term>
<term>Viral perspective</term>
<term>Viral proteins</term>
<term>Viral replication</term>
<term>Viral strategies</term>
<term>Viral transcription</term>
<term>Virol</term>
<term>Virology</term>
<term>Virus</term>
<term>Virus core protein</term>
<term>Virus infection</term>
<term>Virus nonstructural protein</term>
<term>Virus replication</term>
<term>Wang</term>
<term>West china</term>
<term>West china hospital</term>
<term>Wiley periodicals</term>
<term>Yeast</term>
<term>Yeast assay</term>
<term>Yeast host cell</term>
<term>Yeast system</term>
<term>Zhang</term>
<term>Zhou</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Preclinical Research Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering RNA screening, and micro RNA profiling, have been gradually employed in the research of virus–host interactions. Besides, signaling pathways and cellular processes involved in viral–host interactions provide new insights of infectomics in antiviral drug discovery. In this review, we summarize related infectomics approaches in the studies of virus–host interactions, which shed light on the development of novel antiviral drug targets screening.</div>
</front>
</TEI>
</ISTEX>
<PMC>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">7163650</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163650</idno>
<idno type="RBID">PMC:7163650</idno>
<idno type="doi">10.1002/ddr.21027</idno>
<idno type="pmid">NONE</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000899</idno>
<idno type="wicri:Area/Pmc/Curation">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000899</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000856</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000856</idno>
<idno type="wicri:Area/Ncbi/Merge">001350</idno>
<idno type="wicri:Area/Ncbi/Curation">001350</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001350</idno>
<idno type="wicri:doubleKey">0272-4391:2012:Liu Y:infectomics:screening:for</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation>
<nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Drug Development Research</title>
<idno type="ISSN">0272-4391</idno>
<idno type="eISSN">1098-2299</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>
<table-wrap id="nlm-table-wrap-1" xml:lang="en" orientation="portrait" position="anchor">
<table frame="hsides" rules="groups">
<col align="left" span="1"></col>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Preclinical Research</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>Copyright 2012 Wiley-Liss, Inc., A Wiley Company</copyright-holder>
<license>
<license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
</license>
</permissions>
</table-wrap>
</p>
<p>Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering
<styled-content style="fixed-case" toggle="no">RNA</styled-content>
screening, and micro
<styled-content style="fixed-case" toggle="no">RNA</styled-content>
profiling, have been gradually employed in the research of virus–host interactions. Besides, signaling pathways and cellular processes involved in viral–host interactions provide new insights of infectomics in antiviral drug discovery. In this review, we summarize related infectomics approaches in the studies of virus–host interactions, which shed light on the development of novel antiviral drug targets screening.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</PMC>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001410 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001410 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D
   |texte=   Infectomics Screening for Novel Antiviral Drug Targets
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021